This article, written by Sidhesh Phaldessai, provides an overview of geriatric psychopharmacology, including the epidemiology of mental health disorders in the older population, the physiological changes that occur with ageing and their impact on pharmacokinetics and pharmacodynamics, and the use of psychotropic medications in older adults
A major ivermectin study has been withdrawn, so what now for the controversial drug?
+News
A major ivermectin study has been withdrawn, so what now for the controversial drug?
Thursday 2 September 2021, 11:58 AM
[Image: Volodymyr Hryshchenko on Unsplash]
Editor's note: This article was published on The Conversation on 22 July and is republished here in response to growing questions on social media regarding ivermectin. New Zealand Doctor Rata Aotearoa has previously published a statement on the inclusion of ivermectin in the University of Oxford PRINCIPLE trial, which is screening drugs already in use for repurposing as therapy for COVID-19. A link to that article is in the related links below. The PRINCIPLE trial is yet to report findings on ivermectin
By Andrew McLachlan, head of school and dean of pharmacy at the University of Sydney
Ivermectin, an existing drug against parasites including head